NMNilabha Mukherjea

Nilabha Mukherjea

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nilabha Mukherjea has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Preetam Bhardwaj

    Research and Development, Vidyuta, A Lohum Group of Company, Kasna Industrial Area Greater Noida 201310, Uttar Pradesh, India

    2 shared publications
  • Utkarsh Chadha

    Department of Materials Science and Engineering, Faculty of Applied Sciences and Engineering, University of Toronto

    2 shared publications
  • Anusuiya Bora

    Bioinformatics Working Group, Burnet Institute, Melbourne, Australia

    1 shared publication
  • Arghya Chakravorty

    School of Bio Science and Technology, Vellore Institute of Technology, Vellore, Tamilnadu—632014, India

    1 shared publication
  • Evelyn Li

    Department of Materials Science and Engineering, Faculty of Applied Sciences and Engineering, University of Toronto, Toronto, Ontario ON M5S 2Z9, Canada

    1 shared publication
  • Ishi Gupta

    School of Electronics Science and Engineering (SENSE), Vellore Institute of Technology, Vellore, Tamilnadu—632014, India

    1 shared publication

Latest Publications

  • Open Access

    Current Progress in Black Phosphorus Nanomaterials: Exploring Electrochemical, Biomedical, and Biosensor Applications

    by Nilabha Mukherjea, Ruhi Ranjan, Wenxuan (Evelyn) Li, Sandeep Darar, Samantha Makmur, Rishika Basak, Ranjini Mukherjee, Utkarsh Chadha, Senthil Kumaran Selvaraj, Preetam Bhardwaj

    Black phosphorus nanomaterials (BPN), including 2D phosphorene, 1D nanoribbons, and 0D BP quantum dots (BPQDs) exhibit superior electronic performance, remarkable biocompatibility, and tunable bandgap energy. They present immense potential in a variety of fields involving electronics, energy storage, biosensing, and biomedical applications. Despite these favorable characteristics, there are some significant obstacles impeding the widespread adoption of BPN, which includes their degradation in moisture, light, and oxygen-rich environments, difficulties in achieving scalable, high-quality BPN production and instability in electrocatalysis further limit their practical applications. Future work will revolve around optimizing BPN synthesis, thoroughly examining the degradation mechanisms, maintaining BPN stability, and comprehending the biosafety of BP analogues and polymers. In particular, the review suggests exploring BP-metal/metal oxide nanostructure composites, as well as conducting additional research on BPQD-based nanocomposites for biological imaging and drug delivery. Development of efficient anti-degradation strategies, advancement of synthesis techniques, and a deeper understanding of the characteristics and potential applications of BPN will unlock their immense potential across various fields.


  • Open Access

    Review—Magneto-Electrochemical-based Biosensors Devices for Recognition of Tumour Vesicles from Blood Plasma

    by Anusuiya Bora, Rashi Sharma, Ishi Gupta, Mahika Singh, Nilabha Mukherjea, Yuvraj Ranjan Bartaria, Utkarsh Chadha, Preetam Bhardwaj, Srinivasan Latha, Arghya Chakravorty

    Today, cancer is analyzed after it has metastasized throughout the body. This understanding demands earlier identification of cancer to enable better opportunities for a cure. Viable and well-defined strategies to discover cancer and clinical determination are the need of the hour. Biosensors are devices intended to recognize a particular natural analyte by recognizing an organic element (i.e., protein, DNA, RNA) to produce the signals as an electrical signature that can be distinguished and investigated. The utilization of biosensors in disease recognition and observation holds immense potential in diagnosis and treatment. Biosensors can detect cancer biomarkers and decide drug adequacy at different objective destinations. Innovations attributed to biosensors can give a quick and exact location, dependable imaging of cancer cells, observe angiogenesis and disease metastasis, and have the capacity to decide the adequacy of anticancer chemotherapy for specialists. This review briefly summarizes the growing utilization of magneto-electrochemical biosensors as indicative devices and some of its future uses of biosensor innovation.